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Abstract
Objective: Analysis of the T-cell receptor (TCR) repertoire in the cerebrospinal
fluid (CSF) of patients with multiple sclerosis (MS) can reveal antigen-specific
immune responses potentially implicated in the disease process. We applied a
new unbiased deep-sequencing method for TCR repertoire analysis to accu-
rately measure and compare receptor diversity and clonal expansions within the
peripheral and CSF-trafficking T-cell populations of patients with MS and con-
trol individuals with idiopathic intracranial hypertension (IIH). Methods:
Paired blood and CSF TCR b-chain libraries from five MS patients and five IIH
controls were sequenced, yielding a total of 80 million reads. Results: Although
TCR repertoire diversity was greater in the blood and CSF compartments of
MS patients when compared with IIH controls, it is notable that the frequency
of clonal expansions was also significantly higher in both compartments of MS
patients. Highly expanded T-cell clones were enriched in the CSF compartment
of MS patients compared to peripheral blood, very few of them were detected
in both compartments. Interpretation: Collectively, our data provide a proof of
principle that private compartmentalized T-cell expansion exists in the intrathecal
space of MS patients.
Introduction
Multiple sclerosis (MS) is a neuroinflammatory disorder
that affects over 2.5 million people worldwide. The
occurrence of clinical relapses and inflammatory lesions
in MS patients is associated with the infiltration of T cells
in the central nervous system (CNS), which potentially
react with myelin proteins and drive the inflammatory
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and demyelinating process.1 Although the etiology of MS
remains unknown, a number of environmental factors
including viral infection (e.g., Epstein–Barr virus),2 vita-
min D deficiency, and smoking may lead to a dysregu-
lated adaptive immunity in genetically susceptible
individuals.3 Treatments for MS have primarily involved
modulation or suppression of the immune response.4
T-cell receptor (TCR) complementary-determining
region 3 (CDR3) length spectratyping has been used as a
tool to identify skewing of the TCR repertoire in the
peripheral blood (PB) of patients with MS,5 as well as in
brain-infiltrating T cells and the cerebrospinal fluid (CSF)
compartment.6,7 In one study, the expansion of immun-
odominant clones in the CSF compartment correlated
with neurological exacerbation and the TCR repertoire
normalized with clinical remission.8 Sequence analysis in
CD4+ and CD8+ T cells infiltrating actively demyelinating
MS lesions reveals that the majority of CD4+ T-cell popu-
lation was more heterogeneous compared to CD8+ T
cells, which were represented in 35% of total clones in
one MS case.9 However, spectratyping and conventional
sequencing methods do not allow sufficient throughput
to sequence large numbers of TCRs and reliably charac-
terize the repertoire. The advent of deep sequencing and
its application to analysis of the TCR repertoire has now
enabled the accurate identification and quantification of
individual clones in complex polyclonal populations.10
To interrogate the peripheral and CSF T-cell repertoire
in MS patients, we applied an unbiased method to
amplify and deep sequence TCR b-chain rearrangements
present in unsorted and nonstimulated cells from these
compartments. As controls, samples were also processed
from individuals with idiopathic intracranial hypertension
(IIH), a disorder characterized by increased intracranial
pressure of unknown cause.11 Significantly enriched high-
frequency clones were present in the CSF of MS patients,
suggesting a compartmentalized expansion of disease-rele-
vant T cells. By contrast, the number of high-frequency
clones found in the CSF of controls was not different
from the PB compartment.
Methods
Patients and sample collection
Paired PB and CSF samples were collected from five
relapsing–remitting MS patients and five IIH controls. All
patients were assessed under the care of the Neurology
Unit at Charing Cross Hospital, Imperial College Health-
care NHS Trust, London, UK. None of the MS patients
included in this study was receiving any form of
immunotherapy at the time of sample collection. Periph-
eral blood mononuclear cells (PBMCs) were purified by
density gradient centrifugation (Ficoll-HyPaqueTMPlus;
Amersham Bioscience, Piscataway, NJ, USA) and a total
of 106 cells was stored in RNAlaterTM solution (Ambion,
Waltham, MA, USA) at 80°C until RNA extraction. All
CSF samples were obtained via nontraumatic collection
assessed at the time of lumbar puncture by visual inspec-
tion and microscopic examination. CSF cells were also
cryopreserved in RNAlaterTM solution.
TCRb library preparation
The V-CDR3-J region of the TCRb chain was amplified
from unsorted PBMCs (1 9 106) and CSF cells (3.7 9 104
to 2.2 9 105) isolated from MS patients and IIH controls.
The TCRb library generated for high-throughput DNA
sequencing was prepared according to a previously pub-
lished protocol with minor modifications.12 Briefly, mRNA
was extracted using immunomagnetic columns (Miltenyi
Biotec, Germany) following the manufacturer’s protocol.
cDNA was generated using a template-switch anchored
reverse-transcription polymerase chain reaction (RT-PCR)
based on the SMARTer pico cDNA PCR Synthesis Kit
(Clontech, Mountain View, CA, USA). The final cDNA
product was then subjected to a clean-up step using PCR
columns (Nucleospin II; Macherey-Nagel, Germany). To
amplify the V-CDR3-J region of the TCRb chain, a nested
PCR was performed using a pair of primers, one binding
the SMARTer oligonucleotide region (5’-AAGCAGTGG-
TATCAACGCAGAGTAC-3’), and the other binding the
TCRb constant region (5’-TGCTTCTGATGGCTCAAACA-
CAGCGACCT-3’). The qPCR assays were run using the
Kapa HiFi system (Kapa Biosystems, Wilmington, MA,
USA) as follows: one cycle at 95°C for 5 min; five cycles at
98°C for 20 sec and 72°C for 1 min; and 35 cycles at 98°C
for 20 sec and 68°C for 1 min. TCRb DNA library from
each sample was purified using the e-Gel 2% agarose sys-
tem (Invitrogen, USA) and a unique band of ﬃ650 bp size
was collected into a well filled with RNase/DNase-free
water. A second PCR was performed to add an Illumina
adaptor and a unique index barcode to each individual
sample. Library size and quality were measured using an
Agilent Bioanalyzer High Sensitivity DNA Chip (Agilent,
USA) and library concentration was calculated using Kapa
Illumina Library Quantification Assay (Kapa Biosystems,
Santa Clara, CA, USA).
High-throughput sequencing and
bioinformatics analysis
High-throughput sequencing was performed by the Geno-
mic Core Facility of the Medical Research Center (MRC)
at Imperial College London. A total of 2 nmol of each
sample (n = 20) was pooled for high-throughput
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sequencing on the HiSeq 2500 platform (Illumina, USA).
A total of 80-million paired TCRb sequences consisting
of 150 bases at 5’ forward and 3’ reverse orientation were
generated. This sequencing protocol was developed and
validated as described previously.12 Read 1 (5’ forward
orientation) was sequenced using the designed Illumina
primer, whereas read 2 (3’ reverse orientation) was
sequenced using a pool of 13 primers binding the TCRb J
region at a final concentration of 100 lM each (Invitro-
gen, USA). TCRb annotation was performed by combin-
ing a custom Java program written in-house and the
BLAST program developed by the National Center for
Biotechnology Information. Briefly, the V and J germline
genes of a TCRb read were identified first, and the CDR3
was determined by finding the conserved cysteine at 5’
end and the conserved phenylalanine at the 3’ end.
Unique and productive TCRb combinations (V-D-J) were
collapsed to determine the count (TCR in-frame reads).
For each combination, the number of nucleotides con-
tributed by the germline V, D, and J genes was deter-
mined together with the number of nucleotide additions.
Shannon entropy (diversity), species richness, and even-
ness were calculated for each TCRb repertoire by using
the R package, Vegan. Entropy and richness were normal-
ized by calculating the maximum Shannon entropy and
maximum combination richness for each repertoire based
on the cell count used for library generation. The calcu-
lated Shannon entropy and combination richness were
then divided by the respective maxima to return a num-
ber between 0.0 and 1.0. For each repertoire, the average
and standard deviation were calculated for germline
index, CDR3 length, and number of nucleotide additions.
Custom Perl scripts were used to calculate the distribu-
tion of CDR3 length, V-J pairing percentage, and amino
acid compositions of each CDR3 position, as well as
whole CDR3s from all of the annotated TCRb sequence
reads in each subject and group.
Statistics
All statistical analyses were performed in Prism (http://
www.graphpad.com/scientific-software/prism/) or R
(http://www.r-project.org/). Clone frequencies observed in
each subject (http://data.ninds.nih.gov/Jacobson/Alessan-
dra/index.html) were first converted to a percent total fre-
quency value by dividing each clone frequency by the
cumulative frequency observed across all clones for the
same sample. Degree of expansion per clone was then cal-
culated by taking the Log2 transform of the percent total
frequency value. To compare richness, diversity, and clone
expansion between sample classes (i.e., MS and IIH), the
unpaired nonparametric Wilcoxon signed rank T-test was
used (a = 0.05). To compare expansion for clones observed
across compartments (i.e., PB and CSF), the paired non-
parametric Wilcoxon signed rank sum test was used
(a = 0.05). In addition, we also calculated the
p-value by applying the Leave-One-Out (LOO) test on the
Figures 1A-B, 2A-B.
By applying the phylogenetic tree analysis, alignment of
CDR3 amino acid sequences from shared clonotypes was
(A) (B)
Figure 1. Richness and diversity of the T-cell receptor (TCR) b repertoire in the peripheral blood and cerebrospinal fluid (CSF). TCRb richness
(number of unique TCRb clonotypes) was significantly greater in the peripheral blood (PB) than in the CSF for all subjects. The unpaired
nonparametric T-test was applied with p-value 0.0039 (A). TCRb diversity (number of unique TCRb clonotypes per sample normalized by cell
count) was also cumulatively higher in PB compared with CSF. LOO p-value test ranged 0.0078–0.027 (B). LOO, Leave-One-Out.
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used to investigate relatedness. The sequence logo from
groups of related clonotypes was used to identify the
amino acid motifs.
Study approval
This study received institutional ethical approval and all
subjects provided written informed consent at Imperial
College Healthcare NHS Trust.
Results
Subjects and sequencing data
Clinical, demographic, and biological sample informa-
tion for the five relapsing–remitting MS patients and
five IIH controls included in this study is shown in
Table 1. The two groups were age and sex matched. All
patients with MS met the McDonald diagnostic crite-
ria,13 and subject MS-4 had gadolinium enhancement
on magnetic resonance imaging of the brain. There
were no significant differences in PB or CSF white
blood cell counts between MS patients and controls.
Total numbers of TCRb in-frame sequence reads were
not significantly different between MS patients and con-
trols for the PB and/or CSF compartments. On average,
4,445,954 reads were sequenced from the PB
compartment and 3,768,585 reads were sequenced from
the CSF compartment for each subject (Supplementary
Section, Table S1).
Richness and diversity of the TCRb
repertoire are higher in peripheral blood
compared with CSF
The statistically equivalent number of TCRb in-frame
reads between the PB and CSF (unpaired parametric
T-test, P = 0.41; Table S1) enabled us to compare reper-
toires across the two compartments with confidence.
Our initial analysis evaluated the number of unique pro-
ductive TCRb combinations (defined here as richness)
between PB and CSF across all subjects. As shown in
Figure 1A, richness in the PB compartment was signifi-
cantly higher than in the CSF (P = 0.0019). Likewise, we
also compared the level of T-cell diversity, estimated as
the number of unique TCRb clonotypes per sample nor-
malized by cell count, between PB and CSF across all
subjects. As with richness, diversity in the PB compart-
ment was significantly higher compared with CSF
(P = 0.013, Fig. 1B). However, the magnitude of this
difference in diversity was less striking compared with
the difference in richness, the latter presumably reflect-
ing the higher numbers of T cells present in the PB
samples.
(A) (B)
Figure 2. Diversity of the TCRb repertoire in the peripheral blood and cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients and idiopathic
intracranial hypertension (IIH) controls. A significantly higher diversity was detected in the PB (A) Leave-One-Out (LOO p-value test ranged
0.015–0.063) and CSF compartment (B) (LOO p-value test ranged 0.019–0.063) of MS patients compared to IIH controls. PB, peripheral blood.
TCR, T-cell receptor.
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Diversity of the TCRb repertoire is higher in
the peripheral blood and CSF of MS patients
compared with IIH controls
To estimate the complexity of the TCRb repertoire in MS
patients compared with IIH controls, we evaluated clono-
typic diversity in each immune compartment with respect
to disease status. TCRb diversity was significantly greater
in the PB and CSF of MS patients compared with IIH
controls (Fig. 2A and B). The difference observed in the
CSF may indicate the presence of a larger polyclonal
repertoire in the intrathecal compartment of MS patients.
As expected, the TCRb diversity was higher in the PB
than the CSF.
Greater clonal T-cell expansions are present
in the peripheral blood and CSF of MS
patients compared with IIH controls
As the level of TCRb diversity in a sample does not pro-
vide any direct information on the degree of clonal
expansion, we examined the frequency of each individual
clone from those five MS patients and five IIH controls.
Expansion, defined here as the frequency of each unique
TCRb sequence (i.e., clonotypes) in the total repertoire,
was significantly higher in the PB and CSF of MS patients
compared with IIH controls (log of % total clonotypes
with P < 1016; Fig. 3A and B). Investigation of expansion
by both disease cohort and compartment revealed that:
(1) the number of unique TCRb sequences (clonotypes)
in a repertoire with the greatest frequency would be rep-
resented by <5% of the total repertoire (left of the black
dashed line; Fig. 3C and D); (2) the clonotypes with the
highest frequency (top 5%) were insufficient to explain
the differences in expansion observed between MS
patients (red lines) and IIH controls (green lines); (3) the
differences in expansion between MS patients and IIH
controls were better explained by lower frequency clono-
types (right of the black dashed line; Fig. 3C and D); and
(4) interpretation of expansion was clearer when the aver-
age frequencies for a sample group were used (repre-
sented by the thick red dashed lines for MS patients and
green dashed lines for IIH controls; Fig. 3C and D). Sig-
nificantly increased clonal T-cell expansions were there-
fore present in the TCRb repertoire of MS patients
compared with IIH controls.
A nonshared (private) TCRb repertoire exists
in the CSF compartment compared to
peripheral blood
To evaluate the degree of expansion, defined as the range
of frequencies of expanded TCRb clonotypes, and identify
any differences in distribution between MS patients and
IIH controls, the data were replotted as the average fre-
quencies across clonotypes sorted by degree of expansion
(Fig. 4A and B). Comparing the data by sample group
and compartment, the range of expansion where differ-
ences exist between those five MS patients (red line) and
five IIH controls (green line) becomes notably clear
(shaded area; Fig. 4A and B). This observation allowed us
to examine the V-CDR3-J sequences of individual clones
within the frequency ranges that best separated subjects
by disease status. We defined a clonotype as ‘shared’ if it
was present in the PB or CSF of all subjects within a dis-
ease group. Comparing the V-CDR3-J recombinations of
Table 1. Demographic, clinical, and biological information.
Subject1
Age
(yr) Sex Diagnosis
EDSS
score
Brain
MRI
CSF
IgG
OCB
WBC in
blood (103/lL)
CSF
volume (mL) WBC in CSF2
MS-1 25 M RRMS 2 MS Negative 1.5 11 2.2 x 105
MS-2 29 F RRMS 1.5 MS Positive 2.0 11 2 x 105
MS-3 33 F RRMS 1.5 MS Positive 1.4 10 1.3 x 105
MS-4 28 F RRMS 1 MS, with enhancement Positive 1.4 11 1.3 x 105
MS-5 41 M RRMS 6 MS Positive 1.8 10 1 x 105
IIH-1 37 F IIH N/A Normal Negative 2.9 12 2 x 105
IIH-2 23 M IIH N/A Normal Negative 2.1 12 2 x 105
IIH-3 34 F IIH N/A Normal Negative 2.1 10 3.7 x 104
IIH-4 33 M IIH N/A Normal Negative 2.7 10 1.2 x 105
IIH-5 34 F IIH N/A Normal Negative 1.5 9 2 x 105
EDSS, expanded disability status scale; MRI, magnetic resonance imaging; WBC, white blood cells; CSF, cerebrospinal fluid; OCB, oligoclonal
bands.
1Characteristics of five multiple sclerosis (MS) patients and five idiopathic intracranial hypertension (IIH) controls are shown.
2Total number of cells used for TCR-b repertoire analysis.
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(A) (B)
(C) (D)
Figure 3. Expansion of TCRb clonotypes in the peripheral blood and cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients and idiopathic
intracranial hypertension (IIH) controls. Frequency of clonal expansion analysis by group samples in peripheral blood (PB) (A) and CSF (B).
Frequency of clonal expansion analysis for each individual subject in PB (C) and CSF (D). Mean values: dashed red line for MS patients, dashed
green line for IIH controls. Average frequencies: thick red line for MS patients, thick green line for IIH controls. TCR, T-cell receptor.
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the shared clonotypes in PB across MS patients (n = 298)
with the shared clonotypes in PB across IIH controls
(n = 252), we found that a subset (n = 94) of these
clonotypes were common (Fig. 4C). By contrast, no
clonotypes were shared in the CSF among any of the five
MS patients and only eight shared clonotypes were found
in the CSF of IIH controls (Fig. 4D). Even though the
probability of shared clones found in the PB compart-
ment of MS patients and IIH controls was increased due
the higher number of cells, these findings would indicate
the presence of private TCRb repertoire expansions in the
intrathecal compartment. All shared CDR3 sequences are
shown in Table S2, S3 and S4.
CDR3 sequence relatedness of expanded
T-cell clonotypes in the peripheral blood
distinguishes MS patients from IIH controls
To explore the possibility that there may be a subset of
clonotypes specific for MS patients, we analyzed the cata-
log of TCRb clonotypes expanded in PB for each patient
group (Fig. 4A–C). As shown in Figure 4C, we identified
(A) (B)
(C) (D)
Figure 4. Distribution of expanded T-cell clonotypes in the peripheral blood and cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients and
idiopathic intracranial hypertension (IIH) controls. Clonotype distribution as a function of expansion in the peripheral blood (PB) (A) and CSF (B) of
MS patients (dashed red line) and IIH controls (dashed green line). Subsets of differentially expanded clones in PB (from 9.9 to 5.1 log
frequency; gray shading) and CSF (from 5.7 to 3.2 log frequency; gray shading) were selected for phylogenetic tree analysis (Fig. 5). Number
of shared clonotypes by CDR3 amino acid sequence across MS patients and IIH controls in PB (C) and CSF (D).
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204 clonotypes in PB that were exclusively shared among
all five MS patients. Likewise, 158 clonotypes were shared
uniquely among all five IIH patients. Phylogenetic tree
cluster analyses (CLC bio) with respect to CDR3 amino
acid sequence similarities for each of these shared
clonotypes were then performed to determine clonal relat-
edness. This analysis is shown for the 204 unique clono-
types in the PB of MS patients in Figure 5A. Twenty-six
clusters were identified that shared common CDR3 motifs
by sequence similarity, and consensus sequence data for
(A)
(B)
Figure 5. CDR3 sequence relatedness of T-cell clonotypes expanded in the peripheral blood. Phylogenetic tree analysis of CDR3 amino acid
sequence similarities in T-cell clonotypes that were differentially expanded against idiopathic intracranial hypertension (IIH) and were shared in PB
across all fivemultiple sclerosis (MS) patients (as shown in Fig. 4A, C). Representative CDR3 motif clusters are shown as sequence logos (A). CDR3
amino acid sequence logo from exclusively shared clonotypes across MS patients (n = 204) and IIH controls (n = 158) (B). PB, peripheral blood.
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each cluster were visualized using web logos (Fig. 5A).
Moreover, when all clusters were compared for related-
ness, a consensus G (glycine) at positions eight and nine
of the CDR3 loop emerged in the MS cohort that differed
from the consensus sequence observed across the 158
shared clonotypes from IIH controls (Fig. 5B). These
results suggest that TCR motifs may distinguish MS
patients from controls in the PB. The corresponding anal-
yses could not be performed for the CSF repertoires
because no shared clonotypes were identified among MS
patients (Fig. 4D).
Compartmentalized expansion of T-cell
clonotypes in the CSF
As the overall frequency of expanded T cells was greater
in the PB and CSF of MS patients compared with IIH
controls (Fig. 3A and B), we asked whether this distri-
bution would be mirrored by differences in the number
of TCRb clonotypes categorized by “degree” of expan-
sion. We classified two extreme groups of clonotypes:
(1) those with <100 in-frame reads (clonal size defined
as “small expansion”); and (2) those with >10,000
in-frame reads (clonal size defined as “hyperexpanded”).
Significantly lower numbers of clonotypes in the small
expansion group were observed in the CSF of MS
patients (P = 0.007) and IIH controls (P = 0.003)
relative to PB, whereas no significant difference was
observed between disease cohorts with respect to CSF
(Fig. 6A). Higher numbers of hyperexpanded clonotypes
were observed in the CSF of MS patients relative to PB,
which did not reach statistical significance most likely
due to a single outlier (P = 0.08), whereas this trend
was not observed in IIH controls (Fig. 6B). However, a
significant difference was observed in the CSF between
MS patients and IIH controls (P = 0.03). These observa-
tions are consistent with a disease-specific enrichment
of highly expanded clonotypes in the CSF of MS
patients.
To determine whether hyperexpanded clonotypes in
the CSF of MS patients were also present in the PB
(Fig. 6B), we examined the number of shared CDR3
amino acid sequences by compartment for each subject
(Table 2). Very few hyperexpanded clonotypes in the
CSF were found in PB across either of the disease
groups (average 2.06% of total sequences in CSF).
Moreover, only a single clonotype (from >10,000 clones)
identified in the CSF of all subjects (V4.3-CASSQR-
LAGSTDTQYF-J2.3) was also present in PB. The rarity
of these public clonotypes and the low frequency of any
shared sequences between anatomical sites support the
interpretation that the vast majority of T-cell clonotypes
detectable in the CSF are compartmentalized to the
intrathecal space.
(A)                                             (B)
Figure 6. Numbers of unique TCRb clonotypes present at different degrees of expansion in the peripheral blood and CSF of MS patients and IIH
controls. Analysis is shown for small expansion clonotypes, defined as clonal size <100 in-frame reads (A), and hyperexpanded clonotypes,
defined as clonal size >10,000 in-frame reads (B). CSF, cerebrospinal fluid. IIH, idiopathic intracranial hypertension. MS, multiple sclerosis. TCR,
T-cell receptor.
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Discussion
Immune cell entry into the CNS is tightly controlled
under physiological conditions and immune surveillance
is localized to the perivascular and subarachnoid spaces
(part of the CSF compartment).14 Trafficking of T lym-
phocytes across the blood–brain or blood–CSF barrier is
known to play a crucial role in the initiation of an
inflammatory response in the CNS of patients with MS
and is a major therapeutic target in this disorder.
Although there are reports of biased TCRb chain reper-
toire profiles in the CSF of patients with MS,7,15,16 a lack
of sequencing depth and clonal skewing due to in vitro
expansion potentially complicate the interpretation of
these data. To avoid these pitfalls, we used an unbiased
molecular technique to amplify and deep sequence TCRb
rearrangements present in unsorted T cells isolated from
the PB and CSF of relapsing–remitting MS patients and
IIH controls. It is notable that IIH is widely regarded as a
disorder resulting from abnormalities in CSF volume
homeostasis. Chronic inflammation has been implicated
in this condition,11 and CSF oligoclonal bands (OCBs)
were recently identified in 30% of cases.17 However, no
serological or CSF indices of inflammation were detected
in the IIH controls studied here.
Although TCRb repertoire diversity was higher in both
the PB and CSF of MS patients compared with IIH con-
trols, expanded clonotypes were significantly more fre-
quent across both compartments in MS patients. In the
frequency ranges best differentiating MS and IIH, few
clonotypes were shared among all subjects in PB and
none was shared in CSF. Phylogenetic tree analysis of the
shared clonotypes from PB revealed potentially distinctive
CDR3 motifs in MS patients.
Our analyses of the dataset first examined richness,
defined as the absolute number of unique TCRb clono-
types,18 and diversity, defined as the fraction of unique
clonotypes in a sample normalized by cell count, in PB and
CSF. Richness of the TCRb repertoire was much lower in
CSF compared with PB, likely explained by the higher
number of T cells obtained from unsorted PB samples
compared with CSF (approx. 5 9 105 T cells in PB vs.
1 9 105 T cells in CSF). However, the number of input
cells was used to normalize TCRb repertoire diversity by
applying Shannon’s entropy algorithm, and the number of
total in-frame reads were not significantly different between
groups. We therefore felt confident comparing repertoire
diversity by compartment and subject. In addition, we
applied the Leave-One-Out statistical test to reinforce the
significant p-value between our groups of five subjects.
Diversity of the TCRb repertoire was lower in CSF com-
pared with PB in all subjects. A recent study using a differ-
ent molecular approach (multiplex PCR for library
preparation) reported a highly diverse TCRb repertoire in
the PB and CSF of MS patients and controls with other
neurological disorders.19 By contrast, we found greater
TCRb diversity in the PB and CSF of MS patients com-
pared with IIH controls. Different methodologies and
patient cohorts may underlie the diverging results. Using
deep sequencing of the TCRb repertoire across four differ-
ent groups of healthy donors, Britanova et al. demon-
strated that repertoire diversity decreased significantly with
age.20 Another recent study also demonstrated a decline in
TCR repertoire diversity linked to the number of na€ıve T
cells in elderly subjects.18 As the higher TCR repertoire
diversity observed in the PB and CSF of MS patients com-
pared with IIH controls cannot be explained by age differ-
ences in our subject groups, we suggest that this difference
Table 2. Hyperexpanded T-cell clonotypes (clonal size >10,000 in-frame reads) shared between PB and CSF of MS patients and IIH controls.
Subject Total sequences in PB
Total sequences
in CSF
Number of shared
clones CSF (n/total)
Shared sequences
(% CSF repertoire)
Clone
V-CDR3-J
MS-1 72,414 1,757,415 0/105 0% –
MS-2 342,597 700,041 4/43 0.1% V7.2-CASSPGYSGYEQYF-J2.7
V7.6-CASSLEPGRNEKLF-J1.4
V7.2-CASSLGGGISYEQYF-J2.7
V7.2-CASSPLAGGTYNEQF-J2.1
MS-3 51,234 4,036,432 1/185 2.59% V4.1-CASSQDRYRQNTEAF-J1.1
MS-4 244,397 2,202,176 0/75 0% –
MS-51 9,631,112 11,386 – – –
IIH-1 834,970 985,623 1/20 3.7% V12.3-CASQQGSGSYEQYF-J2.7
IIH-2 399,951 3,085,051 0/24 0% –
IIH-3 294,631 553,871 0/19 0% –
IIH-4 2,737,399 914,804 0/22 0% –
IIH-5 336,773 3,694,466 1/109 9.2% V7.2-CASSLGAGGSTQYF-J2.3
PB, peripheral blood.
1Subject MS-5 had one T-cell clonotype classified as hyperexpanded in the CSF compartment.
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reflects a dysregulated T-cell response associated with MS.
Clearly, these proof-of-principle observations need to be
extended to a large cohort of MS patients and controls.
The analysis of clonotype frequency revealed signifi-
cantly higher mean clonal frequencies in MS patients
compared with IIH controls across both compartments,
albeit with a more prominent difference in CSF. The
greater diversity of PB and CSF repertoires in MS
patients, discussed above, reassures us against the possi-
bility that these higher clonal frequencies may be due to
sampling error (e.g., from lower numbers of input cells).
By analyzing the cumulative frequency curves, we were
able to delineate the range of frequencies that contributed
most to the observed differences. Through a density plot
representation, we were then able to define a specific
range of clonal expansion that revealed differences in the
number of clonotypes between MS patients and IIH con-
trols in both PB and CSF. This analysis allowed us to
more selectively target a search for the presence of shared
T-cell clonotypes 21 within compartments and between
disease groups. Although we identified a robust number
of shared clonotypes in the PB across all five MS patients
(n = 204) as well as in all five controls (n = 158), very
few shared clonotypes were observed in the CSF across
IIH controls, and no clonotypes were common in the
CSF across all MS patients. These results suggest that the
CSF compartment may have a more private or “non-
shared” TCR repertoire compared with PB. Accordingly,
pathogenic T-cell responses may be driven by individual
clonotypes specific for a variety of antigen(s) present
solely in the CNS. Recently, sharing of predominant
T-cell clones between CNS lesions, CSF, and blood CD8+
T cells was found in three MS patients when the TCR
b-chain repertoire was analyzed using a multiplex amplifi-
cation approach for V- J genes.22 Clonally infiltrating,
expanded CD8+ and CD4+ T-cell in demyelinating MS
lesions pattern II were also identified in the CSF compart-
ment of MS patients after ex vivo culture expansion.23
The phylogenetic tree analysis of “public” T-cell clono-
types found exclusively in the PB of MS patients revealed
a group of 26 clusters, which showed amino acid
sequence relatedness across the CDR3 loop. Although the
antigen specificity of these TCRs remains unknown, we
found a consensus motif with a conserved glycine (G)
residue at CDR3 positions eight and nine in MS patients
that was not conserved in IIH controls. Further studies
are needed to determine whether this motif constitutes an
MS-specific signature and potential biomarker of disease
in the peripheral TCRb repertoire.
After investigating the clones present at different density
in the intermediate- to high-frequency ranges in MS and
controls and their relatedness, we focused our attention on
“hyperexpanded” versus “small” expanded clonotypes.
While the number of small clonotypes was significantly
greater in PB than in CSF, both in MS and in IIH, and did
not differ in the CSF between MS and IIH (Fig. 6A), there
was a clear trend toward a higher number of hyperex-
panded clonotypes in the MS patients’ CSF compared with
that in the PB; and the number was significantly higher
than that in controls (Fig. 6B). We suggest that these
results reflect a disproportional clonal expansion of T cells
in the CSF of MS patients. As very few of these hyperex-
panded clones observed in the CSF were also present in the
PB compartment, the data support the notion of a strongly
compartmentalized intrathecal expansion of T cells in MS.
In conclusion, we used an unbiased method for TCR
repertoire analysis to demonstrate clonal T-cell expan-
sions in the CSF of MS patients. The detection of highly
expanded private clonotypes in the intrathecal compart-
ment is consistent with the possibility of disease-indu-
cing T-cell activation by CNS-resident stimuli and
signals. Although the antigen specificity of these clono-
types remains unknown, our analysis will inform the
selection of relevant TCRb sequences for such down-
stream studies.
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